RxDoctor Payments Data

Kristen Price

Family · van Wert, OHNPI 1194165266

Payments from drug & device makers

$1,727in general payments, 2019–2025

Across 113 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$794
  • AstraZeneca$214
  • Lilly USA, LLC$122
  • Novo Nordisk$121
  • Exact Sciences$75
  • Amgen$65
  • plus $335 from 14 others

What the payments were for

  • Food & beverage$1,727100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,727 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide21$30,913
Breztri AerosphereBudesonide/Glycopyr/Formoterol30$25,295
Soliqua 100-33Insulin Glargine/Lixisenatide14$21,375
JanuviaSitagliptin Phosphate19$20,917
OzempicSemaglutide19$20,079
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$19,227
EliquisApixaban16$18,896
MyrbetriqMirabegron14$8,655
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$4,503
ValiumDiazepam11$3,008
Desvenlafaxine Succinate ErDesvenlafaxine Succinate11$2,721
Novolog FlexpenInsulin Aspart13$1,924
Duloxetine Hcl52$1,751
Atorvastatin Calcium267$1,482
Pantoprazole Sodium126$1,427

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$122$30,91321 claims
AstraZenecaBreztri Aerosphere$214$25,29530 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$13$21,37514 claims
Novo NordiskOzempic$121$20,07919 claims
GSKTrelegy Ellipta$33$19,22721 claims
PfizerEliquis$39$18,89616 claims
AbbVieSynthroid$794$87816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,812 family providers in Ohio.

Other family in van Wert

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →